Cargando…
Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward
Peptide receptor radionuclide therapy (PRRT) is a highly effective anti-cancer treatment modality for patients with non-resectable, metastasized neuroendocrine tumors (NETs). During PRRT, specific receptors that are overexpressed on the cancer cells are targeted with a peptide labeled with a DNA-dam...
Autores principales: | Feijtel, Danny, de Jong, Marion, Nonnekens, Julie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493789/ https://www.ncbi.nlm.nih.gov/pubmed/32101125 http://dx.doi.org/10.2174/1568026620666200226104652 |
Ejemplares similares
-
Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival
por: Tamborino, Giulia, et al.
Publicado: (2022) -
Inter and intra-tumor somatostatin receptor 2 heterogeneity influences peptide receptor radionuclide therapy response
por: Feijtel, Danny, et al.
Publicado: (2021) -
In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib
por: Feijtel, Danny, et al.
Publicado: (2023) -
Looking Back and Looking Forward
por: Rao, Jaya K
Publicado: (2007) -
Looking Back, Looking Forward
por: Chang, Hyejung
Publicado: (2012)